Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Clinical trial NCT01465802 · COMPLETED
Trial details
- NCT number
- NCT01465802
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-26
- Primary completion
- 2015-05-18
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.